Lycia Therapeutics, Inc. Common Stock (LYCA) Stock Price

LYCAStock
$32.20
Market Cap$1.68B
P/E—
PEG Ratio—
Div yield—
Beta—

LYCA Share Price Chart

Favorite Metrics

VGM Score73.90

Industry Peers — Biological Products(191)

SymbolValue ScoreGrowth ScoreMomentum ScoreP/S Ratio (TTM)Revenue Growth TTM (YoY)Gross Margin (TTM)EPS Growth (5Y)Price
LYCALycia Therapeutics, Inc. Common Stock
——B————$32.20
AMGNAmgen IncDCB6.5x8.2%74.7%2.9%$466.83
GILDGilead Sciences IncCBB6.7x6.5%80.0%133.6%$168.56
MRNAModerna, Inc. Common StockFBA35.9x13.1%39.0%—$224.83
ARGXargenx SE American Depositary SharesDAB10.6x61.4%90.0%—$966.37
BIIBBiogen Inc. Common StockCDB3.6x2.3%74.0%-18.8%$254.88
RVMDRevolution Medicines, Inc. Common StockF—B189.2x———$173.31
BNTXBioNTech SE American Depositary ShareCCC7.9x-10.7%79.1%—$85.69
NBIXNeurocrine Biosciences IncCBB4.6x38.0%98.0%2.3%$168.38
EXELExelixis IncCBA6.8x9.1%96.3%31.1%$69.39
HALOHalozyme Therapeutics, Inc.DBB6.9x41.1%82.4%22.9%$100.83

About Lycia Therapeutics, Inc. Common Stock

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.